Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 23, 1993 - Issue 7
11
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Metabolic fate of a new dihydropyridine calcium antagonist, CD-349, in rat and dog

, , , &
Pages 747-759 | Received 21 Dec 1992, Accepted 06 May 1993, Published online: 23 Apr 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

H. Nakabeppu, M. Asada, T. Oda, Y. Shinozaki & T. Yajima. (1996) Plasma and urinary metabolites of efonidipine hydrochloride in man. Xenobiotica 26:2, pages 229-239.
Read now
N. Ogawa, T. Hirose, K. Fukushima, T. Suwa & T. Satoh. (1995) Metabolism of a nitrate ester, dihydropyridine derivative in rabbit hepatic microsomes and cytosol. Xenobiotica 25:3, pages 283-290.
Read now

Articles from other publishers (2)

Naoyoshi Ogawa, Takuya Hirose, Kiyomi Fukushima, Toshio Suwa & Tetsuo Satoh. (1995) GSH-independent denitration of the nitrate ester of a dihydropyridine derivative in rabbit hepatic cytosol. Biochemical Pharmacology 49:2, pages 141-146.
Crossref
Z Hernández-Gallegos, PA Lehmann F, E Hong, F Posadas & E Hernández-Gallegos. (1995) Novel halogenated 1,4-dihydropyridines: Synthesis, bioassay, microsomal oxidation and structure-activity relationships. European Journal of Medicinal Chemistry 30:5, pages 355-364.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.